product summary
Loading...
company name :
Sino Biological
product type :
protein
product name :
Human IL4 / Interleukin-4 Protein
catalog :
GMP-11846-HNAE-L
quantity :
25 µg
price :
348 USD
more info or order :
image
image 1 :
Sino Biological GMP-11846-HNAE-L image 1
product information
Catalog Number :
GMP-11846-HNAE-L
Product Name :
Human IL4 / Interleukin-4 Protein
Product Type :
Protein
Host Species :
E. coli
Conjugation :
Native
Size :
25 µg
List Price :
348 USD
Gene ID :
P05112-1
Product Description :
A DNA sequence encoding the mature form of human IL4 isoform 1 (P05112-1) (His25-Ser153) was expressed and purified with an initial Met.
SpeciesSummary :
Human
ALTnames :
BCGF1,BCGF-1,BSF1,BSF-1,IL-4,MGC79402
Purity :
≥ 95 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC.
Buffer :
Supplied as powder that is lyophilized from a 0.2 μm filtered solution in PBS and Trehalose.
Packaging :
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.
Storage :
Samples are stable for up to thirty-six months from date of receipt at ≤ -20℃ Store it under sterile conditions at ≤-20℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
more info or order :
company information
Sino Biological
Building 9, No.18 Kechuang 10th St, BDA, Beijing, 100176
marketing@sinobiological.com
https://www.sinobiological.com
86 400-890-9989
headquarters: China
Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones. Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements. In addition, Sino Biological offer pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates.